Verona, Italy

Nadia Conti

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Spa. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadia Conti. Retrieved from https://idiyas.com/inventor/nadia-conti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nadia Conti – Innovating Excitatory Amino Acids

Introduction

Nadia Conti is an accomplished inventor based in Verona, Italy. With a passion for innovations in the field of pharmaceuticals, she has made significant contributions to the development of novel compounds.

Latest Patents

Nadia holds a patent for "3-Substituted-indole-2-carboxylic acid derivatives as excitatory amino acids." This innovative compound presents potential benefits in neurobiology and could have far-reaching implications for various therapeutic applications.

Career Highlights

Nadia is currently employed at Glaxo Wellcome Spa, a leading global healthcare company. Her work there focuses on advancing drug discovery and development through innovative scientific methods.

Collaborations

Throughout her career, Nadia has collaborated with notable colleagues such as Romano Di Fabio and Elisabetta De Magistris. These partnerships have bolstered her research efforts and contributed to the successful outcomes of their projects.

Conclusion

Nadia Conti’s work exemplifies the spirit of innovation in the pharmaceutical industry. Her patent reflects her commitment to advancing science and improving health outcomes, making her a key figure in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…